- Home
- BVS vs PCN Comparison
BVS vs PCN Comparison
Compare BVS & PCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BVS
- PCN
- Stock Information
- Founded
- BVS 2011
- PCN 2001
- Country
- BVS United States
- PCN United States
- Employees
- BVS N/A
- PCN N/A
- Industry
- BVS Biotechnology: Electromedical & Electrotherapeutic Apparatus
- PCN Investment Managers
- Sector
- BVS Health Care
- PCN Finance
- Exchange
- BVS Nasdaq
- PCN Nasdaq
- Market Cap
- BVS 883.7M
- PCN 728.5M
- IPO Year
- BVS 2021
- PCN N/A
- Fundamental
- Price
- BVS $11.41
- PCN $13.78
- Analyst Decision
- BVS Strong Buy
- PCN
- Analyst Count
- BVS 3
- PCN 0
- Target Price
- BVS $15.00
- PCN N/A
- AVG Volume (30 Days)
- BVS 297.3K
- PCN 218.7K
- Earning Date
- BVS 11-05-2024
- PCN 01-01-0001
- Dividend Yield
- BVS N/A
- PCN 9.73%
- EPS Growth
- BVS N/A
- PCN N/A
- EPS
- BVS N/A
- PCN N/A
- Revenue
- BVS $555,061,000.00
- PCN N/A
- Revenue This Year
- BVS $11.24
- PCN N/A
- Revenue Next Year
- BVS $6.77
- PCN N/A
- P/E Ratio
- BVS N/A
- PCN N/A
- Revenue Growth
- BVS 10.40
- PCN N/A
- 52 Week Low
- BVS $3.90
- PCN $10.70
- 52 Week High
- BVS $14.38
- PCN $14.48
- Technical
- Relative Strength Index (RSI)
- BVS 43.94
- PCN 34.70
- Support Level
- BVS $10.95
- PCN $14.00
- Resistance Level
- BVS $11.54
- PCN $14.16
- Average True Range (ATR)
- BVS 0.48
- PCN 0.10
- MACD
- BVS -0.04
- PCN -0.04
- Stochastic Oscillator
- BVS 13.84
- PCN 15.22
About BVS Bioventus Inc.
Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.
About PCN Pimco Corporate & Income Strategy Fund
PIMCO Corporate & Income Strategy Fund is a closed-end management investment company. Its objective is to seek high current income. The secondary investment objective of the fund is capital preservation and appreciation. It invests in corporate bonds and notes, non-agency mortgage-backed securities, asset-backed securities, short-term instruments, and others.